Article Text

Download PDFPDF
Short report
Centres of Excellence Course in Pharmacogenetics, 25–28 June 2012
  1. Cristina Lucía Dávila-Fajardo1,
  2. Jesse J Swen2,
  3. Tahar van der Straaten2,
  4. Henk-Jan Guchelaar2
  1. 1Department of Clinical Pharmacy, San Cecilio University Hospital Granada, Granada, Spain
  2. 2Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands
  1. Correspondence to Dr Jesse J Swen, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, P.O. Box 9600, NL 2300 RC Leiden, The Netherlands; J.J.Swen{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Pharmacogenetics, promising the end of ‘one size fits all’ drugs and of trial and error in pharmacotherapy, is often predicted to be one of the first clinical applications in the postgenomic era. Yet, while pharmacists are often considered as ideal candidates to translate the new pharmacogenetic knowledge to clinical practice, many do not feel adequately informed about the possibilities of genetic testing and its applicability to their patients. For this reason, the Spanish Association of Hospital Pharmacists organised an Excellence Course in Pharmacogenetics on 25–28 June. The course was attended by 15 Spanish clinical pharmacists aiming to understand the basic concepts and potential clinical applications of pharmacogenetics to hospital pharmacy practice. …

View Full Text


  • CLD-F and JJS contributed equally

  • Contributors Each author participated in the preparation of appropriate portions of the text.

  • Funding Ipsen Pharma funded this course.

  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.